<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Clinical Neurosciences</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/D353BA4A-E082-4536-9091-2CE1BB44DC0F"><gtr:id>D353BA4A-E082-4536-9091-2CE1BB44DC0F</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:surname>Jezzard</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C9EF0FB5-941A-47D1-AB13-A6115D438A18"><gtr:id>C9EF0FB5-941A-47D1-AB13-A6115D438A18</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:otherNames>M</gtr:otherNames><gtr:surname>Matthews</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0100811"><gtr:id>07E97DEE-1393-4CAF-8B2F-3CBD6819E73B</gtr:id><gtr:title>Towards Quantitative fMRI for Serial Studies of the Normal and Diseased Brain</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0100811</gtr:grantReference><gtr:abstractText>The relatively new technique of functional magnetic resonance imaging (fMRI) has provided a uniquely non-harmful way of studying the way the human brain works. We are able to use this technology to study both healthy people, and people with brain diseases. To date, however, it has been difficult to make rigorous comparisons of brain activity in the same person across different points in time (for example, from week to week) or across different people (for example, between healthy people and patients). This is because of the complexity of the signals that are measured by fMRI. In this proposal we will work to improve our understanding of the factors that influence the fMRI signal that we measure, with the intention of being able to make better comparisons between scanning sessions and between different people. We will make measurements and test theories in healthy human volunteers who will undergo MRI scans, and towards the end of the grant period we apply the procedures that we develop to patients with blocked blood supply to the brain. Once this is accomplished the results of this proposal would make fMRI a much better tool for doctors and scientists to use in order to monitor brain diseases, and to develop new treatment methods.</gtr:abstractText><gtr:technicalSummary>Functional magnetic resonance imaging (fMRI) is a potentially powerful non-invasive method for measuring brain activity in human subjects via changes in blood oxygenation and flow. The technique has been used widely to study the location of specialized brain processing. However, an impediment to making quantitative assessment of brain activity is the indirect nature of the fMRI response, and its biophysical and physiological complexity. The aim of this work is to address the issues of quantitative comparison, particularly across-session and across-subject effects. Our main goals are: (1) To use MRI methods to estimate normal oxygen-flow coupling in healthy individuals across brain areas and across scanning sessions, and to test the hypothesis that the coupling between oxygen utilisation and blood flow is relatively constant within a brain region across sessions, and to examine variability across cortical regions. (2) Using the knowledge obtained on oxygen-flow coupling within individuals, we wish to understand variations in fMRI sensitivity that is observed across the normal population and to test the hypothesis that the underlying oxygen-flow coupling is relatively constant between healthy individuals, but that other factors, principally CBV-CBF coupling, result in differences in BOLD sensitivity. (3) Finally, we wish to apply these principles to the study of patients with compromised haemodynamic capacity to test the hypothesis that changes in haemodynamic response rather than the underlying neuronal activity may explain a significant proportion of the observed changes in BOLD response over time. Accomplishment of these goals would have significant impact on the ability to study changes in brain function over time, both in normal subjects and in patients. The latter application would have considerable impact on the study of brain disease using fMRI methods, which are currently highly qualitative, and would provide measures of brain metabolism as well as offering methods of comparing populations (e.g. patients versus healthy subjects).</gtr:technicalSummary><gtr:fund><gtr:end>2008-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2003-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>566542</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>GlaxoSmithKline collaboration</gtr:description><gtr:id>4C81E0A2-CB1B-467A-B2C1-B378BA394EFE</gtr:id><gtr:impact>New MRC grant - G0802179</gtr:impact><gtr:outcomeId>BBE7DD81CCA-1</gtr:outcomeId><gtr:partnerContribution>Access to PET technologies</gtr:partnerContribution><gtr:piContribution>Proposed research collaboration and wrote grant</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>GlaxoSmithkline</gtr:description><gtr:id>4BD51FF6-029A-4E2C-BC6E-BD8C2DA84912</gtr:id><gtr:impact>GSK funded a studentship that interlinked with this grant and helped develop improved methods for acquisition of perfusion imaging data.</gtr:impact><gtr:outcomeId>716413FA19B-1</gtr:outcomeId><gtr:piContribution>Hosted a studentship in collaboration with GSK. Supervised the student.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Public lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B12231FB-3638-475E-B2F7-022153B7899A</gtr:id><gtr:impact>Approx. 50 attendees at a university public outreach event.

Several people asked for further information to be sent to them.</gtr:impact><gtr:outcomeId>Bcvw6JcU22e</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>regular briefings to newspaper journalists</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>96DD16B1-69F4-4B1D-9A4C-961EAF9CC089</gtr:id><gtr:impact>Am regularly telephoned and emailed by newspaper science journalists to provide background information and leads relating to imaging developments.

impossible to gauge</gtr:impact><gtr:outcomeId>5B02AE5DE6D</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>participation in MRC Strategic Workshop on PET Imaging</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8DF5096B-F258-427E-96AD-C0C2133EC8CF</gtr:id><gtr:impact>Helping construct strategy for PET neuroimaging needs in the UK

Report completed and being acted upon</gtr:impact><gtr:outcomeId>0DC1A4BC0DF</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at local 6th Form College</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>07A0EBAE-3031-42F7-A900-706A567E7C59</gtr:id><gtr:impact>Talk to the Year 12 and 13 Science Club at Cherwell School on the principles and applications of Magnetic Resonance Imaging.</gtr:impact><gtr:outcomeId>5808bca8dd5533.34081678</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Several presentations to alumni of University and College</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A9A4A128-54CD-4AAD-B546-9EE027B170F5</gtr:id><gtr:impact>Several presentations of work at alumni events held across the University and College.

Interest in participation as a human volunteer in the studies, and potential interest in donating money.</gtr:impact><gtr:outcomeId>D534D5488C6</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007,2008,2009,2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Siemens Healthcare Advisory Committee</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>DEE26693-BADC-45CA-BE05-B7B37B7DF3EC</gtr:id><gtr:impact>Siemens Healthcare invited PJ to attend an internal strategy meeting of 12 international experts in the field to discuss the future role of arterial spin labelling in their MRI scanners. The ultimate audience was the Product Definition Group of Siemens Healthcare, who determine what products they wish to take forward.

The work that we are doing on real-time feedback ASL was identified by the panel as a top priority for future development so that it could eventually be translated as a clinical product on commercial MRI scanners.</gtr:impact><gtr:outcomeId>R43Ag5Gbvsx</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011,2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>3864276</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Centres for Doctoral Training</gtr:description><gtr:end>2022-09-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>EP/L016052/1</gtr:fundingRef><gtr:id>12121DA5-8F25-47CE-BFBC-982EE3B482ED</gtr:id><gtr:outcomeId>545a5d20403d85.83755063</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>144400</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>GlaxoSmithKline Studentship</gtr:description><gtr:end>2009-09-02</gtr:end><gtr:fundingOrg>GlaxoSmithKline (GSK)</gtr:fundingOrg><gtr:id>18FB1537-32F4-4D75-AE64-265C9DD55561</gtr:id><gtr:outcomeId>8133584BCB50</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2006-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK/EPSRC Cancer Imaging Centre (named investigator)</gtr:description><gtr:end>2013-02-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>8E4A0254-49A2-4F73-A95D-BE471C026A3D</gtr:id><gtr:outcomeId>F773E68C1AD0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>127012</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Oxford Biomedical Research Centre</gtr:department><gtr:description>NIHR Oxford Biomedical Research Centre</gtr:description><gtr:end>2011-02-02</gtr:end><gtr:fundingOrg>Oxford University Hospitals NHS Foundation Trust</gtr:fundingOrg><gtr:id>D33B9890-1843-443F-B806-656C870D6E2D</gtr:id><gtr:outcomeId>FE2A01D108E0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>8922000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust/MRC/DoH etc. Clinical Research Facility (co-PI)</gtr:description><gtr:end>2013-03-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>EF44A9FE-C67D-4152-B7F0-3C3FD3F9534C</gtr:id><gtr:outcomeId>EDE20F46E2A0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Research Grant</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>4DFB06F6-E4C8-4981-85E3-CFF19864CE2D</gtr:id><gtr:outcomeId>59B2A8A9AA80</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have developed and published a number of novel non-invasive MRI methods for measuring cerebral physiology. These include novel methods of data acquisition optimization; new methods for measurement of cerebral blood flow; new methods for measurement of cerebral blood volume; new methods for measuring blood oxygenation; and new methods for calibrated and quantitative functional MRI.</gtr:description><gtr:id>5AC6E505-32B4-4D40-99AE-3BB89E223DBE</gtr:id><gtr:impact>These techniques are being translated into clinical practice. A prominent example of this is in Oxford where the techniques will be used in the newly funded Acute Vascular Imaging Centre</gtr:impact><gtr:outcomeId>4FB4DC8AA74</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>New MRI techniques</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have developed a new method of human blood flow measurement using MRI that is better tailored to individual measurements, and to making an accurate measurement in pathological situations (e.g. cerebrovascular disease)</gtr:description><gtr:id>AF44404A-A9A6-4F55-9EC2-7C9E8CAB1F09</gtr:id><gtr:impact>We plan to use this technique in studying patient populations, and are are about to collaborate with the Juelich Forschungszentrum where they have a combined PET and MRI scanner. They will benefit from our pulse sequence code and we will benefit from access to their PET technology.</gtr:impact><gtr:outcomeId>GyRAon6a599</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Novel MRI pulse sequence for CBF measurement</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>1F795428-EF7D-4302-86B6-9B9A8468B3C5</gtr:id><gtr:title>Measurement of cerebral blood volume in humans using hyperoxic MRI contrast.</gtr:title><gtr:parentPublicationTitle>Journal of magnetic resonance imaging : JMRI</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7bc6c1796a6a5f03eacb17740e0fc12"><gtr:id>a7bc6c1796a6a5f03eacb17740e0fc12</gtr:id><gtr:otherNames>Bulte D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1053-1807</gtr:issn><gtr:outcomeId>4AD68BA4145</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>988EA048-026E-4C3C-8BCB-F051297B6EED</gtr:id><gtr:title>Dynamic forcing of end-tidal carbon dioxide and oxygen applied to functional magnetic resonance imaging.</gtr:title><gtr:parentPublicationTitle>Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a3f199c67ce3ed319a595f16de2c447d"><gtr:id>a3f199c67ce3ed319a595f16de2c447d</gtr:id><gtr:otherNames>Wise RG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0271-678X</gtr:issn><gtr:outcomeId>17275829CD3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A4BDCB00-3490-49CB-A5E3-06ED71D7C44F</gtr:id><gtr:title>Modelling vascular reactivity to investigate the basis of the relationship between cerebral blood volume and flow under CO2 manipulation.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c6013651766d0e98999fd0b857ed3b75"><gtr:id>c6013651766d0e98999fd0b857ed3b75</gtr:id><gtr:otherNames>Piechnik SK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>8325BE2BD21</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>848ECF4C-39C8-44FB-AAD3-9B51F2EA9317</gtr:id><gtr:title>Comparison of hypercapnia-based calibration techniques for measurement of cerebral oxygen metabolism with MRI.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0f243829cb0976ac70409c19fa3b2da9"><gtr:id>0f243829cb0976ac70409c19fa3b2da9</gtr:id><gtr:otherNames>Bulte DP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0740-3194</gtr:issn><gtr:outcomeId>9E3169463B0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2BAF8AF0-86D4-43FF-9350-B5EF9BD7437E</gtr:id><gtr:title>Modeling the effects of dispersion and pulsatility of blood flow in pulsed arterial spin labeling.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/244d3e1fe4096fac6b2d82917d43a5fb"><gtr:id>244d3e1fe4096fac6b2d82917d43a5fb</gtr:id><gtr:otherNames>Gallichan D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0740-3194</gtr:issn><gtr:outcomeId>CCA097CF27C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93DE15F2-0695-4F51-8D74-9E6080ECD4F1</gtr:id><gtr:title>Quantitative measurement of cerebral physiology using respiratory-calibrated MRI.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0f243829cb0976ac70409c19fa3b2da9"><gtr:id>0f243829cb0976ac70409c19fa3b2da9</gtr:id><gtr:otherNames>Bulte DP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>pm_15623_23_22209811</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>109A3EC1-4072-47EB-830A-03BF84494B21</gtr:id><gtr:title>Variation in the shape of pulsed arterial spin labeling kinetic curves across the healthy human brain and its implications for CBF quantification.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/244d3e1fe4096fac6b2d82917d43a5fb"><gtr:id>244d3e1fe4096fac6b2d82917d43a5fb</gtr:id><gtr:otherNames>Gallichan D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0740-3194</gtr:issn><gtr:outcomeId>26B215451E6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40E8B1F7-0FE9-4A0B-A4F8-46CC13BAACC5</gtr:id><gtr:title>Characterization of regional heterogeneity in cerebrovascular reactivity dynamics using novel hypocapnia task and BOLD fMRI.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02bb247de007f772243f7fadd1af6c1e"><gtr:id>02bb247de007f772243f7fadd1af6c1e</gtr:id><gtr:otherNames>Bright MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>EEC1460BB8C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7947E13-30AB-49B8-AE4F-BADB7FFC4D4F</gtr:id><gtr:title>The effect of basal vasodilation on hypercapnic and hypocapnic reactivity measured using magnetic resonance imaging.</gtr:title><gtr:parentPublicationTitle>Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02bb247de007f772243f7fadd1af6c1e"><gtr:id>02bb247de007f772243f7fadd1af6c1e</gtr:id><gtr:otherNames>Bright MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0271-678X</gtr:issn><gtr:outcomeId>m4oguPPpGFU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4411C06-E25E-4DB8-AAA6-7E8F01AC2C81</gtr:id><gtr:title>Flow-metabolism coupling in human visual, motor, and supplementary motor areas assessed by magnetic resonance imaging.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/62b74230a7505bbfe6a8b30f55a8fb11"><gtr:id>62b74230a7505bbfe6a8b30f55a8fb11</gtr:id><gtr:otherNames>Chiarelli PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0740-3194</gtr:issn><gtr:outcomeId>5E219C49158</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37786B1B-DEA8-4528-AD86-87984D5D2782</gtr:id><gtr:title>Functional changes in CSF volume estimated using measurement of water T2 relaxation.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c6013651766d0e98999fd0b857ed3b75"><gtr:id>c6013651766d0e98999fd0b857ed3b75</gtr:id><gtr:otherNames>Piechnik SK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0740-3194</gtr:issn><gtr:outcomeId>0B82B731700</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D7D36156-C248-485A-A1C9-395D003FC735</gtr:id><gtr:title>Measuring the effects of remifentanil on cerebral blood flow and arterial arrival time using 3D GRASE MRI with pulsed arterial spin labelling.</gtr:title><gtr:parentPublicationTitle>Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aeeb5792a9837fd285a284a40b57692e"><gtr:id>aeeb5792a9837fd285a284a40b57692e</gtr:id><gtr:otherNames>MacIntosh BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0271-678X</gtr:issn><gtr:outcomeId>76C2E19F0B1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF21D4C3-1C65-45BE-AA8B-F6FA9426EAA2</gtr:id><gtr:title>Sources of systematic bias in hypercapnia-calibrated functional MRI estimation of oxygen metabolism.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/62b74230a7505bbfe6a8b30f55a8fb11"><gtr:id>62b74230a7505bbfe6a8b30f55a8fb11</gtr:id><gtr:otherNames>Chiarelli PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>9A48857817D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8A4CACB6-8A27-4298-99AE-D6A417B3A201</gtr:id><gtr:title>A calibration method for quantitative BOLD fMRI based on hyperoxia.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/62b74230a7505bbfe6a8b30f55a8fb11"><gtr:id>62b74230a7505bbfe6a8b30f55a8fb11</gtr:id><gtr:otherNames>Chiarelli PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>4C84967A7A5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2889844-1E45-4EE0-8247-A22DC0C67EA8</gtr:id><gtr:title>Cerebral perfusion response to hyperoxia.</gtr:title><gtr:parentPublicationTitle>Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0f243829cb0976ac70409c19fa3b2da9"><gtr:id>0f243829cb0976ac70409c19fa3b2da9</gtr:id><gtr:otherNames>Bulte DP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0271-678X</gtr:issn><gtr:outcomeId>1B07C666A11</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>888EDF70-4124-49D2-9D8B-42D2CAFD1B77</gtr:id><gtr:title>Optimal design of pulsed arterial spin labeling MRI experiments.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fea6ec6cc1da7cdd03a47d7186ab7685"><gtr:id>fea6ec6cc1da7cdd03a47d7186ab7685</gtr:id><gtr:otherNames>Xie J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0740-3194</gtr:issn><gtr:outcomeId>6685001C9C2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>023E639A-18E9-4739-A46E-937F6C536BEC</gtr:id><gtr:title>Measurement of relative cerebral blood volume using BOLD contrast and mild hypoxic hypoxia.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a3f199c67ce3ed319a595f16de2c447d"><gtr:id>a3f199c67ce3ed319a595f16de2c447d</gtr:id><gtr:otherNames>Wise RG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0730-725X</gtr:issn><gtr:outcomeId>L9gzWiU1eBt</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0100811</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>67</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>12A0B409-0C29-4056-9092-2D86E44017F3</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>1.4  Methodologies and measurements</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>